KR860004147A - 에피더민의 제조방법 - Google Patents

에피더민의 제조방법 Download PDF

Info

Publication number
KR860004147A
KR860004147A KR1019850008249A KR850008249A KR860004147A KR 860004147 A KR860004147 A KR 860004147A KR 1019850008249 A KR1019850008249 A KR 1019850008249A KR 850008249 A KR850008249 A KR 850008249A KR 860004147 A KR860004147 A KR 860004147A
Authority
KR
South Korea
Prior art keywords
epidermin
methanol
butanol
acetic acid
chloroform
Prior art date
Application number
KR1019850008249A
Other languages
English (en)
Other versions
KR930002736B1 (ko
Inventor
귄터 베르너(외4) 롤프
Original Assignee
베첼, 좀머
닥터 칼 토매 게젤샤프트 미트 베쉬랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843440423 external-priority patent/DE3440423A1/de
Priority claimed from DE19853523478 external-priority patent/DE3523478A1/de
Application filed by 베첼, 좀머, 닥터 칼 토매 게젤샤프트 미트 베쉬랭크터 하프퉁 filed Critical 베첼, 좀머
Publication of KR860004147A publication Critical patent/KR860004147A/ko
Application granted granted Critical
Publication of KR930002736B1 publication Critical patent/KR930002736B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • C12R2001/45—Staphylococcus epidermidis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

내용 없음

Description

에피더민의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 에피더민(Epidermin)의 완전한 산 가수분해물의 아미노산 크로마토그램이다(닌히드린 염색, λ＝570㎜).
제3도는 에피더민의 UV 스펙트럼이다.
제10도는 본 발명의 배지에 대하여 생존하는 박테리아의 수 및 마이크로코쿠스루테우스에 대한 활성을 비교한 그래프이다.

Claims (2)

  1. 스타필로코쿠스 에피더미디스(Staphylococcus epidermidis) DSM 3095를 2 내지 4%의 육즙 등의 질소원, 1 내지 3%의 당 또는 당알코올의 탄소원 및 0.25 내지 1%의 탄산염 및/또는 0.25 내지 0.5%의 알칼리토금속의 수산화물로 구성되는 복합 영양배지 용액중에서 34 내지 37℃의 호기 조건하에 성장시킨 후, 세포 및 무기염을 제거하고; 배양모액을 pH 8에서 n-부탄올로 추출하고, 부탄올 추출물을 증발시켜 그 잔류물을 메탄올에 용해시킨 다음 이 용액을 에테르 침전에 의해 지방성분을 제거하거나, 배양모액을 아크릴레이트 또는 폴리스티렌을 주재로 하는 중합체로 처리하고, 흡착된 에피더민을 메탄올/진한염산(99:1)에 의해 수지로 부터 유리시킨 다음 이 용액을 암모니아로 중화시키고, 진공중에서 증발 농축시켜, 생성된 활성물질을 단리시키고; 상기에서 단리한 물질을 겔크로마토그래피[메탄올/아세트산(95:5)를 사용하여 세파덱스 LH-20에서]하여 다른 저분자량 펩티드, 아미노산 및 염을 분리 제거하고; 일차적으로, n-부탄올/에틸아세테이트/0.1N 아세트산(3:1:3)의 시스템을 사용하여 액체-액체 분배를 수행하고, 연속하여, 이차적으로, 기선상에 남아있는 에피더민을 2-부탄올/0.05N암모늄 아세테이트(1:1) 중성 시스템을 사용하여 분배하는 크레이그의 다중 역류 분배를 수행하고; 용출물을 동결건조시켜 무색분말 형태의 순수한 에피더민을 단리시킴을 특징으로 하는, 하기의 일차구조를 가지며, 그 아미노산 조성이 Asn(1), Pro(1), Gly(2), Ala(2), He(2), Phe(2), Lys(2), Lan(2), β-Me-Lan(1), Dhb(1), Tyr(1) 및 S-(2-아미노비빌)-D-시스테인(1)인 항생물질 에피더민의 제조, 단리 및 정제방법.
    상기 구조식에서, N-말단에 인접한 개개의 티오에테르아미노산의 반이 D배치이다.
  2. 제1항에 있어서, 하기의 추가 특성을 갖는 에피더민의 제조방법.
    a. 형태:무색분말, b. 용해도:물/빙초산 또는 메탄올/빙초산의 혼합물에 매우 쉽게 용해; 저급 알코올에 용해; 클로로포름, 아세톤, 디에틸에테르, 석유 에테르에 불용. c. 실리카겔 플레이트 상에서 염색 반응;닌히드린, 염소/TDM[TDM＝4,4'＝비스-(디메틸아미노)-디페닐메탄], 오르신/술푸르산, 아니스알데히드/술푸르산. 254㎜의 UV에서, 물을 분무하여 비-파괴검출. d. 박층 크로마토그래피:실리카겔 플레이트 상품 60F254(Merck)를 사용하였다. 시스템 A:클로로포름/메탄올/17% 암모니아 (2/2/1) Rf＝0.73
    시스템 B:클로로포름/메탄올/17% 암모니아 시스템 C:n-부탄올/빙초산/물
    (70/35/10) Rf＝0.30 (4/1/1) Rf0.73
    e. HPLC:제7도 참조. f. 안정성 pH2 내지 pH7에서 안정. 그이상의 pH에서 활성이 급강하. g. 분자량:약 2160(음이온부재). h. U.V.흡수스펙트럼:수용액에서 λmax×267nm(제3도 참조). i. IR흡수스펙트럼:브롬화 칼륨 펠렛상 시료의 IR 스펙트럼(제4도). i. NMR 스펙트럼 1H-NMR 스펙트럼:제5도 13C-NMR 스펙트럼:제6도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850008249A 1984-11-06 1985-11-05 에피더민의 제조방법 KR930002736B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19843440423 DE3440423A1 (de) 1984-11-06 1984-11-06 Antibiotisches polypeptid, verfahren zu seiner herstellung, dieses polypeptid erzeugender stamm von staphylococcus epidermidis, dieses polypeptid enthaltende zubereitungsformen und seine verwendung zur bekaempfung infektioeser erkrankungen
DEP3440423.6 1984-11-06
DEP3523478.4 1985-07-01
DE19853523478 DE3523478A1 (de) 1985-07-01 1985-07-01 Antibiotisches polypeptid, verfahren zu seiner herstellung, dieses polypeptid erzeugender stamm vom staphylococcus epidermidis, dieses polypeptid enthaltende zubereitungsformen und seine verwendung zur bekaempfung infektioeser erkrankungen

Publications (2)

Publication Number Publication Date
KR860004147A true KR860004147A (ko) 1986-06-18
KR930002736B1 KR930002736B1 (ko) 1993-04-09

Family

ID=25826263

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850008249A KR930002736B1 (ko) 1984-11-06 1985-11-05 에피더민의 제조방법

Country Status (13)

Country Link
EP (1) EP0181578B1 (ko)
JP (2) JPH0670078B2 (ko)
KR (1) KR930002736B1 (ko)
CA (1) CA1277617C (ko)
DE (1) DE3583987D1 (ko)
DK (1) DK172818B1 (ko)
ES (1) ES8702924A1 (ko)
FI (1) FI82073C (ko)
HK (1) HK63795A (ko)
IL (1) IL76956A (ko)
NO (1) NO164039C (ko)
NZ (1) NZ214067A (ko)
PT (1) PT81436B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023096177A1 (ko) * 2021-11-26 2023-06-01 코스맥스 주식회사 에피더미디박테리움 케라티니 추출물이 함침된 다공성 실리카 및 그의 피부상태 개선 용도

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637384B2 (ja) * 1985-09-21 1994-05-18 株式会社資生堂 皮膚化粧料
EP0350810B1 (de) * 1988-07-15 1993-09-29 Dr. Karl Thomae GmbH Verfahren zur Gewinnung, Isolierung und Reinigung von Epidermin
DE3938140A1 (de) * 1989-11-16 1991-08-08 Beiersdorf Ag Desodorierende kosmetische mittel
ATE145817T1 (de) * 1992-09-10 1996-12-15 Sara Lee De Nv Mundpflegemittel antibakterieller aktivität
ES2157985T3 (es) * 1993-08-20 2001-09-01 Novartis Ag Metodo para la prevencion y el tratamiento de la mastitis bovina.
WO1995030751A1 (en) * 1994-05-07 1995-11-16 Ciba-Geigy Ag Lanthionine-containing antimicrobial compound
AU5098396A (en) * 1995-04-07 1996-10-23 Kuyus-Stiftung Cosmetic composition for treating cellulite
SE9602496D0 (sv) 1996-06-20 1996-06-20 Bengt Guss Method and means for producing a fibrinogen binding protein and its use in biotechnology
JP2006176406A (ja) * 2003-03-11 2006-07-06 Asahi Kasei Pharma Kk ペプチド系抗生物質

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023096177A1 (ko) * 2021-11-26 2023-06-01 코스맥스 주식회사 에피더미디박테리움 케라티니 추출물이 함침된 다공성 실리카 및 그의 피부상태 개선 용도

Also Published As

Publication number Publication date
FI854316A (fi) 1986-05-07
FI82073C (fi) 1991-01-10
NO854405L (no) 1986-05-07
CA1277617C (en) 1990-12-11
HK63795A (en) 1995-05-05
DK172818B1 (da) 1999-08-02
JPH0732704B2 (ja) 1995-04-12
NO164039C (no) 1990-08-22
PT81436B (pt) 1988-01-22
ES548544A0 (es) 1987-01-16
FI82073B (fi) 1990-09-28
IL76956A0 (en) 1986-04-29
JPS61158997A (ja) 1986-07-18
NZ214067A (en) 1991-05-28
KR930002736B1 (ko) 1993-04-09
NO164039B (no) 1990-05-14
PT81436A (de) 1985-12-01
IL76956A (en) 1991-07-18
EP0181578A3 (en) 1988-08-17
EP0181578B1 (de) 1991-09-04
FI854316A0 (fi) 1985-11-04
DE3583987D1 (de) 1991-10-10
EP0181578A2 (de) 1986-05-21
JPH06113826A (ja) 1994-04-26
ES8702924A1 (es) 1987-01-16
DK509985D0 (da) 1985-11-05
DK509985A (da) 1986-05-07
JPH0670078B2 (ja) 1994-09-07

Similar Documents

Publication Publication Date Title
ALLGAIER et al. Epidermin: sequencing of a heterodet tetracyclic 21‐peptide amide antibiotic
Blombäck [44] Derivatives of glutamine in peptides
Diddens et al. On the transport of tripeptide antibiotics in bacteria
KR860004147A (ko) 에피더민의 제조방법
Morris et al. The isolation and characterization of γ-l-glutamyl-l-tyrosine and γ-l-glutamyl-l-phenylalanine from soybeans
McCalla et al. Reaction of N-methyl-N′-nitro-N-nitrosoguanidine with protein: formation of nitroguanido derivatives
Marzotto et al. Reversible acetoacetylation of amino groups in proteins
PT90592B (pt) Processo para a preparacao do antibiotico galidermina e de composicoes farmaceuticas e cosmeticas que o contem
Jakobi et al. Cyanopeptolin SS, a disulphated depsipeptide from a water bloom: structural elucidation and biological activities
Rudman et al. Isolation of two lipolytic pituitary peptides
US5302582A (en) Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products
Aoyagi et al. Studies of Peptide Antibiotics. III. Cyclo-(L-valyl-L-ornithyl-L-leucyl-D-phenylalanylglycyl) 2
US4107158A (en) Process for making an octapeptide useful for the treatment of diabetes
Isowa et al. Total synthesis of ferrichrome
Carter et al. Biosynthesis of viomycin. I. Origin of αβ-diaminopropionic acid and serine
SU1232148A3 (ru) Способ получени инсулина человека
KHAN et al. SYNTHESIS OF THE DODECAPEPTIDE‐α MATING FACTOR OF SACCHAROMYCES CEREVISIAE
SUZUKI et al. Selective Cleavage of tert-Butyloxycarbonyl Protecting Group with Dilute Organic Sulfonic Acid without Decomposition of Tryptophan Residue
AU596082B2 (en) Antibiotic polypeptide
Jeannoda et al. Isolation and partial characterization of glabrin, a neurotoxin from Cnestis glabra (Connaraceae) root barks.
Paiva et al. The importance of the N-terminal end of angiotensin II for its pressor and oxytocic activities
Birr et al. The hexa-and pentapeptide extension of proalbumin I. Chemical synthesis of serum albumin propeptides
EP0667355A1 (de) Hirudinderivate und Verfahren zu deren Herstellung
SAMEJIMA et al. Bifidus factors in carrot. I. Purification and some properties
Inouye et al. Synthesis of Corticotropin Peptides. XVI. The Total Syntheses of Porcine and Human Corticotropins

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050331

Year of fee payment: 13

EXPY Expiration of term